Related Experiment Video
Updated: Oct 17, 2026

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
Anxiolytic Potential of Selected Essential Oils and Their Impact on Motor Function
Alberto Souza Sá Filho1, John Ihayi Ogbu2, Ayobami J Olusola2
1Graduate Program in Pharmaceutical Sciences, Evangelical University of Goiás, Anápolis 75083-515, Brazil.
Abstract:
Plant essential oils (EOs) exhibit promising anxiolytic activity, but their application may be constrained by adverse motor effects arising from interactions with neural circuits controlling movement. Here, we investigated the anxiolytic-like effects and motor impairment liability of EOs from Pimenta pseudocaryophyllus, Melissa officinalis, Matricaria chamomilla, Lippia alba, Salvia rosmarinus, Ocimum basilicum, Spiranthera odoratissima, and Cymbopogon citratus, integrating computational target prediction with behavioral pharmacology. Prioritized EO constituents were subjected to target prediction, molecular docking, and 100-ns molecular dynamics simulations to identify molecular mechanisms potentially associated with motor impairment. Male and female Swiss mice received oral vehicle 10 mL/kg, EOs (10, 100, or 500 mg/kg) or diazepam (DZP 1 or 5 mg/kg), followed by the evaluation of anxiolytic-like behavior and motor coordination in the elevated plus maze and rotarod test, respectively. In silico analyses involving docking and molecular dynamics simulations of computationally prioritized EO constituents identified candidate targets within M1 and M2 receptors. All EOs exhibited anxiolytic-like activity at the intermediate dose. Motor impairment varied markedly among EOs. Integrating computational target prediction with behavioral assessment identified distinct motor liability profiles among EOs.
Related Concept Videos
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Anxiolytic Drugs: Benzodiazepines and Buspirone
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
